Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Massachusetts General Hospital Researchers’ Diabetes Vaccine Appears to Present Cure 8 Years Later

Researchers at Massachusetts General Hospital in Boston published results from a long-term clinical trial of a tuberculosis vaccine in type 1 diabetes patients that in a long-term follow-up appears to have cured the disease.

Read More »

Novo’s pioneering diabetes pill beats Victoza, Januvia in tests

Novo Nordisk’s experimental diabetes pill, which the company hopes will transform the diabetes market, has proved superior to both Merck & Co.’s Januvia and its own best-selling injectable treatment Victoza in tests.

Read More »

Kallyope, Novo Nordisk Team Up To Tackle Obesity

New York-based Kallyope and Danish company Novo Nordisk signed a research collaboration and option deal to discover novel therapeutics to treat obesity and diabetes.

Read More »

DreaMed Receives FDA Approval for Diabetes Management Software

The U.S. FDA approved for marketing DreaMed Diabetes’ Advisor Pro software to help manage diabetes treatment.

Read More »

Novo Nordisk’s oral diabetes drug beats Jardiance in study

Novo Nordisk said data from a large final-stage study of a pill the company hopes will transform the diabetes market proved better at lowering blood sugar levels than Eli Lilly and Boehringer Ingelheim’s established Jardiance.

Read More »

Delayed calorie disclosure rule takes effect for U.S. food sellers

Many restaurants, supermarkets, convenience stores and movie theaters across the United States are required to start clearly displaying food calorie counts as part of a push to trim expanding American waistlines and control healthcare costs.

Read More »

French Insulin Maker Spurned by Eli Lilly Forges Deal with China’s Tonghua Dongbao

Shares of Adocia were up nearly 30 percent after the French company granted exclusive development and commercialization rights of its insulin products to Tonghua Dongbao Pharmaceuticals in order to provide treatment to the 100 million people in China living with a form of diabetes.

Read More »

FDA approves Toujeo Max SoloStar

The U.S. Food and Drug Administration approved Sanofi’s Toujeo (insulin glargine 300 Units/mL) Max SoloStar, the highest capacity long-acting insulin pen that will be available on the market.

Read More »

AstraZeneca Shows Off New Farxiga Data for Diabetes Patients with Chronic Kidney Disease

AstraZeneca Pharmaceuticals LP’s drug Farxiga could receive a new indication for a subset of diabetes patients based on Phase III data that was released.

Read More »

Smoking tied to higher risk of hearing loss

Smokers may be more likely to develop hearing loss than nonsmokers, and the risk increases with each additional cigarette people smoke on a typical day, a Japanese study suggests.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!


Ad Right Bottom